Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Large Drop in Short Interest

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 15,700 shares, a drop of 29.0% from the February 13th total of 22,100 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Basilea Pharmaceutica Price Performance

Shares of OTCMKTS BPMUF opened at $52.83 on Friday. The company has a quick ratio of 3.27, a current ratio of 4.10 and a debt-to-equity ratio of 5.70. The stock has a fifty day moving average price of $52.83 and a 200 day moving average price of $52.48. Basilea Pharmaceutica has a 1-year low of $38.60 and a 1-year high of $52.83.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.